Reaction Details |
| Report a problem with these data |
Target | D(3) dopamine receptor |
---|
Ligand | BDBM50020217 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_60503 (CHEMBL673332) |
---|
Ki | 0.21±n/a nM |
---|
Citation | van Vliet, LA; Rodenhuis, N; Dijkstra, D; Wikström, H; Pugsley, TA; Serpa, KA; Meltzer, LT; Heffner, TG; Wise, LD; Lajiness, ME; Huff, RM; Svensson, K; Sundell, S; Lundmark, M Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907). J Med Chem43:2871-82 (2000) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
D(3) dopamine receptor |
---|
Name: | D(3) dopamine receptor |
Synonyms: | DOPAMINE D3 | DRD3 | DRD3_HUMAN | Dopamine D3 receptor | Dopamine D3 receptor (D3) | Dopamine D3 receptor (D3R) | Dopamine receptor | Dopamine receptor (D3) | Dopamine receptor D3 |
Type: | n/a |
Mol. Mass.: | 44243.43 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 400 |
Sequence: | MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERAL
QTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILN
LCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTV
CSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQ
QTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRK
LSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHV
SPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
|
|
|
BDBM50020217 |
---|
n/a |
---|
Name | BDBM50020217 |
Synonyms: | (4aR,10bR)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol | 3,5-Dichloro-N-(1-ethyl-pyrrolidin-2-ylmethyl)-2-hydroxy-6-methoxy-benzamide | 4-Propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol | CHEMBL69271 | NAXAGOLIDE HYDROCHLORIDE | PHNO | PHNO,(+) |
Type | Small organic molecule |
Emp. Form. | C15H21NO2 |
Mol. Mass. | 247.3327 |
SMILES | CCCN1CCO[C@H]2[C@H]1CCc1ccc(O)cc21 |
Structure |
|